The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Inferring optimal detection of MTAP homozygous loss (homozygous deletion) in pancreatic cancer: Association with treatment exposure, co-alterations, site of biopsy, and clinical outcomes.
 
Ajeet Gajra
Honoraria - Cardinal Health
Consulting or Advisory Role - AstraZeneca; BeiGene; Cardinal Health; Foundation Medicine; G1 Therapeutics; Genentech; Johnson & Johnson/Janssen; Pfizer; Taiho Oncology
Research Funding - Bristol-Myers Squibb/Celgene/Juno (Inst); Celcuity (Inst); Gilead Sciences (Inst); Jazz Pharmaceuticals (Inst); Jazz Pharmaceuticals (Inst); Merck (Inst); Mirati Therapeutics (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Cardinal Health
Other Relationship - EMOL Health; Exigent Research; National Cancer Care Alliance (NCCA); Quality Cancer Care Alliance
(OPTIONAL) Uncompensated Relationships - Athelo Health
 
Eliane Cortez
Employment - Foundation Medicine
Stock and Other Ownership Interests - Roche
 
Gerald Li
Employment - Foundation Medicine
Stock and Other Ownership Interests - Roche
 
Natalie Danziger
Employment - Foundation Medicine
Stock and Other Ownership Interests - Roche
 
Ryon Graf
Employment - Foundation Medicine
Stock and Other Ownership Interests - Roche
Travel, Accommodations, Expenses - Epic Sciences; Foundation Medicine
 
Jeffrey Ross
Employment - Foundation Medicine
Leadership - Foundation Medicine
Stock and Other Ownership Interests - Foundation Medicine
Consulting or Advisory Role - Tango Therapeutics
Research Funding - Foundation Medicine
 
Daniel King
Stock and Other Ownership Interests - Illumina
Honoraria - Ipsen; Omni Health; Omni Health; Skysis
Patents, Royalties, Other Intellectual Property - I am a joint author on iNav, a tool to computationally identify and navigate patients to cancer care.
 
Christopher Lieu
Consulting or Advisory Role - Flatiron Health (Inst); Pfizer (Inst)
Research Funding - Genentech (Inst)
 
Michael Pishvaian
Stock and Other Ownership Interests - Perthera; Tumor Board Tuesday
Consulting or Advisory Role - Astellas Pharma; Merck; Merus; Moderna Therapeutics; Pfizer; Renovo Rx; Revolution Medicines; Seagen; Serna Bio; Theriva Biologics
Research Funding - Actuate Therapeutics (Inst); Amgen (Inst); Arcus Biosciences (Inst); Astellas Pharma (Inst); BioMed Valley Discoveries (Inst); Boehringer Ingelheim (Inst); Elevation Oncology (Inst); Hutchison MediPharma (Inst); IDEAYA Biosciences (Inst); Lilly (Inst); Lilly (Inst); MEI Pharma (Inst); Merck (Inst); Novartis (Inst); Parabalis (Inst); Pfizer (Inst); Recursion Pharmaceuticals (Inst); Repare Therapeutics (Inst); Seagen (Inst); Takeda (Inst); Tesaro (Inst); Tizona Therapeutics, Inc. (Inst)
Patents, Royalties, Other Intellectual Property - Perthera patient matching algorithm
Travel, Accommodations, Expenses - Astellas Pharma; Merus; RenovoRx; Revolution Medicines